Plain-English translation of NCT07407348 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing survodutide, an experimental medication designed to help with weight management in people living with overweight or obesity. Researchers want to compare two different formulations (versions) of this medication to see if they work the same way in your body. The study involves giving you multiple doses of each formulation to understand how your body absorbs and processes the medication.
Before a new medication can be widely used, researchers need to make sure that different versions of it work equally well. This study will help determine whether the two formulations of this treatment are truly equivalent, which is an important step in making the medication available to patients.
You likely qualify if…
You likely don't qualify if…
You would receive multiple injections of one formulation of the medication, followed by a washout period, then multiple injections of the other formulation (or in the reverse order). During the study, you will have regular clinic visits for blood draws and physical exams to measure how your body handles each version of the medication. The study involves comparing how well each formulation is absorbed so researchers can confirm they are equivalent.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United Kingdom
Phase
Safety & dosing
Sponsor
Boehringer Ingelheim
Enrollment target
~80 participants
Started
March 2026
Primary completion
January 2027
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Boehringer Ingelheim
Boehringer Ingelheim
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.